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Editorial on the Research Topic
Eyeblink Classical Conditioning in Psychiatric Conditions: Novel Uses for a Classic Paradigm
As one of the most basic forms of associative learning, eyeblink conditioning (EBC) is a model 
paradigm with unique utility in the assessment of complex behavioral disorders, including psychi-
atric disorders. Two major EBC paradigms utilized with human subjects are delay EBC [in which 
a conditioned stimulus (CS; e.g., an auditory tone) co-terminates with an unconditioned stimulus 
(US; e.g., a corneal airpuff)] and trace EBC [in which CS presentation is followed after a silent inter-
stimulus interval (termed the “trace” interval by Pavlov) by the US, with no CS-US overlap in time]. 
The neural substrates of EBC in these paradigms are well delineated and include the cerebellum and 
anterior interpositus nucleus, the hippocampus, and prefrontal cortex. Variability in acquisition, 
discrimination, timing, sensitization, and/or extinction of classically conditioned eyeblink responses 
provides insight into the behavioral and neurobiological characteristics of a variety of psychiatric 
and neurological disorders.
In this Research Topic, Kent et al. review the existing literature on EBC studies in schizophrenia, 
perhaps the most studied psychiatric diagnostic group with respect to EBC to date. In their review 
of 15 studies, they report that decreased percent CRs (impaired learning) is the most robust and rep-
licated finding in this population, with equivocal findings associated with CR timing. Importantly, 
differences between schizophrenic and healthy controls in percent CRs appear to be reflective of cer-
ebellar abnormalities—supported by neuroimaging data and data from first-degree relatives—rather 
than confounding issues such as medication use. However, the authors highlight the importance of 
methodological consistency across EBC paradigms for accurate interpretation and synthesis of data 
across studies, an issue critical in the evaluation of any behavioral measure. Bolbecker et al. report 
data on delay EBC in schizophrenia using an analytic approach—hierarchical liner modeling—that 
has the advantages of less restrictive assumptions and inclusion of unequal variances in comparison 
to more traditionally employed analytic approaches, such as repeated measures analysis of vari-
ance. The authors did not find differences between schizophrenic patients and age-matched healthy 
controls in learning rate, but did observe group differences in time to maximal learning level and 
plateau of learning response, with schizophrenic patients exhibiting saturation in learning earlier 
and at a lower level in comparison to healthy controls.
Cheng et al. provide summaries of both animal and human work describing the impact of alcohol 
use disorders in adults and fetal alcohol syndrome in children. EBC studies in these populations have 
illuminated structural and functional differences in both the mature and developing cerebellum, as 
well as learning differences in these diagnostic groups when compared to healthy controls.
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Weiss and Disterhoft emphasize the utility of rabbit EBC for 
assessing cerebro-cerebellar functional connectivity. The role 
of hippocampus, fronto-temporal and cerebellar cortices, and 
of cerebellar deep nuclei has been well characterized in a wide 
variety of normal states as well as dysfunctional psychiatric con-
ditions. Their review concentrates on models of schizophrenia 
and Alzheimer’s dementia, but also points out applications for 
normal aging, Parkinson’s disease, progressive supranuclear palsy, 
alcoholism, and post-traumatic stress disorder (PTSD). Indeed, 
the rabbit EBC model was developed in parallel with assessment 
of human EBC in a series of studies from the laboratories of 
Gormezano, his students, and colleagues, which have allowed 
mechanistic, physiological, and pharmacological assessments to 
be carried out in depth.
Schreurs and Burhans detail development of a preclinical EBC 
extinction model with potential utility for treatment of inap-
propriate conditioned behaviors and hyperarousal in individuals 
suffering from PTSD, whether combat veterans or approximately 
5–25% of the general populace who experience severe anxiety, 
sleeplessness, hypervigilance, and/or flashbacks after trauma 
constitute a group at extreme risk for suicide. Their exposure 
paradigm uses conditioning-specific reflex modification and 
attenuated intensity US presentations to enhance the likely clini-
cal utility for human applications.
Janke et al. discuss dysregulation of brain-derived neurotrophic 
factor (BDNF) in anxiety disorders, including impaired behavioral 
inhibition temperament (BI). They describe facilitated delay EBC 
in both human and animal subjects exhibiting BI. In their animal 
model after EBC, increases in mRNA for hippocampal BDNF 
were observed in both the dentate gyrus and CA3 regions, along 
with upregulation of TrkB receptors and downstream activity-
related cytoskeletal protein (Arc) in the hippocampus, but these 
increases were blunted in the strain showing faster acquisition 
and hyper-sensitivity to both CS and US. Hippocampal BDNF 
administration reversed the behavioral sensitization, suggesting 
treatment strategies that enhance that hippocampal BDNF may 
be effective for a variety of anxiety disorders.
Welsh and Oristaglio provide a secondary analysis of children 
with autism spectrum disorder (ASD) who underwent both 
delay and trace EBC. They grouped children based on their 
diagnosis into either an autistic disorder group or an Asperger’s 
syndrome or Pervasive Developmental Disorder (Asp/PDD) 
group. Neither ASD group showed differences in CR acquisition 
compared to an age- and IQ-matched group of typically devel-
oping (TD) children. However, the groups differed with respect 
to CR timing alterations, with the Asp/PDD group showing 
delayed CR onset and peak latencies during trace conditioning 
that were not observed in the ASD or TD groups. These data 
may illustrate differences in the underlying biology of these two 
diagnostic groups that are expressed as behavioral differences. 
Although the authors indicate that these differences must be 
further tested in a larger trial, these data are representative of the 
types of approaches that are supported by the NIMH’s Research 
Domain Criterion (RDoc) initiative that aims to use a variety 
of approaches, including behavioral phenotyping, to help our 
field better distinguish brain dysfunction among patients with 
psychiatric illnesses.
Similarly, Parker describes the potential for timing tasks to aid 
in our understanding of cognitive impairment across diagnostic 
groups, again in line with the RDoC approach. She asserts that 
tasks that involve temporal processing, such as EBC, can reflect 
connectivity between the cerebellum and frontal cortex, and in 
particular, hypothesizes that the medial frontal cortex plays a 
critical role in cognitive processing that occurs in timing tasks. 
This reciprocal relationship between cerebellar and frontal corti-
cal regions is an important area of further investigation.
Cicchese and Berry also focus on timing and the critical role of 
theta (the 3–7 Hz EEG bandwidth prominent in medial temporal 
lobe) in many forms of learning and memory. They review non-
theta contingent EBC, demonstrating its importance as a model 
system for characterizing neurobiological dysfunction in severe 
cognitive disorders, including schizophrenia, major depression, 
and Alzheimer’s disease. From their animal studies and an exten-
sive review of the human literature, they argue that theta rhythms 
serve to coordinate timing and synchrony of activity in widely 
distributed brain systems critical for acquiring, consolidating, 
and retrieving memories, both for complex cognitive sequences 
and for relatively low-level tasks such as classical EBC.
The studies in this Research Topic highlight the utility of EBC 
in assessing the integrity of cerebellar and medial temporal lobe 
function in both normal and pathological states and support 
wider uses of this behavioral paradigm across a multitude of 
psychiatric disorders. The editors’ earlier work on impaired trace 
EBC in depressed individuals (1) illustrates qualitative diagnostic 
potential for this simple associative learning paradigm in future 
clinical practice. Increased familiarity of clinical practitioners 
with the straightforward methodology required, and adoption 
of standards for EBC testing and adjunct assessments of clinical 
characteristics of populations studied, should still further increase 
the use of this classical conditioning paradigm in diagnostic and 
treatment settings.
aUtHor CoNtriBUtioNS
All authors listed have made substantial, direct, and intellectual 
contribution to the work and approved it for publication.
rEFErENCE
1. Greer TL, Trivedi MH, Thompson LT. Impaired delay and trace eyeblink 
conditioning performance in major depressive disorder. J Affect Disord (2005) 
86:235–45. doi:10.1016/j.jad.2005.02.006 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2017 Greer and Thompson. This is an open-access article distributed 
under the terms of the Creative Commons Attribution License (CC BY). The use, 
distribution or reproduction in other forums is permitted, provided the original 
author(s) or licensor are credited and that the original publication in this journal 
is cited, in accordance with accepted academic practice. No use, distribution or 
reproduction is permitted which does not comply with these terms.
